AAAAAA
Results:
1-15
|
Results: 15
Authors:
Sinclair, SE
Frighetto, L
Loewen, PS
Sunderji, R
Teal, P
Fagan, SC
Marra, CA
Citation: Se. Sinclair et al., Cost-utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke - A Canadian healthcare perspective, PHARMACOECO, 19(9), 2001, pp. 927-936
Authors:
Marra, CA
Esdaile, JM
Guh, D
Fisher, JH
Chalmers, A
Anis, AH
Citation: Ca. Marra et al., The effectiveness and toxicity of cyclosporin A in rheumatoid arthritis: Longitudinal analysis of a population-based registry, ARTH RH ART, 45(3), 2001, pp. 240-245
Authors:
Wai, AO
Frighetto, L
Marra, CA
Chan, E
Jewesson, PJ
Citation: Ao. Wai et al., Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme - A Canadian teaching hospital and ministry of health perspective, PHARMACOECO, 18(5), 2000, pp. 451-457
Authors:
Frighetto, L
Marra, CA
Stiver, HG
Bryce, EA
Jewesson, PJ
Citation: L. Frighetto et al., Economic impact of standardized orders for antimicrobial prophylaxis program, ANN PHARMAC, 34(2), 2000, pp. 154-160
Authors:
Loewen, PS
Marra, CA
Zed, PJ
Citation: Ps. Loewen et al., 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting, CAN J ANAES, 47(10), 2000, pp. 1008-1018
Authors:
Marra, CA
Esdaile, JM
Sun, HY
Anis, AH
Citation: Ca. Marra et al., The cost of COX inhibitors: How selective should we be?, J RHEUMATOL, 27(12), 2000, pp. 2731-2733
Authors:
Marra, CA
Frighetto, L
Quaia, CB
de Lemos, ML
Warkentin, DI
Marra, F
Jewesson, PJ
Citation: Ca. Marra et al., A new ciprofloxacin stepdown program in the treatment of high-risk febrileneutropenia: A clinical and economic analysis, PHARMACOTHE, 20(8), 2000, pp. 933-942
Authors:
Marra, CA
de Alaniz, MJT
Citation: Ca. Marra et Mjt. De Alaniz, Calcium deficiency modifies polyunsaturated fatty acid metabolism in growing rats, LIPIDS, 35(9), 2000, pp. 983-990
Authors:
Loewen, PS
Marra, CA
Marra, F
Citation: Ps. Loewen et al., Systemic review of the treatment of early Lyme disease (vol 57, pg 157, 1999), DRUGS, 59(3), 2000, pp. 476-476
Authors:
Marra, CA
Patrick, DM
Marra, F
Citation: Ca. Marra et al., A cost-effectiveness analysis of pneumococcal vaccination in street-involved, HIV-infected patients, CAN J PUBL, 91(5), 2000, pp. 334-339
Authors:
Balen, RM
Marra, CA
Zed, PJ
Cohen, M
Frighetto, L
Citation: Rm. Balen et al., Cost-effectiveness analysis of enoxaparin versus unfractionated heparin for acute coronary syndromes - A Canadian hospital perspective, PHARMACOECO, 16(5), 1999, pp. 533-542
Authors:
Marra, FO
Frighetto, LO
Marra, CA
Sleigh, KM
Stiver, HG
Bryce, EA
Reynolds, RP
Jewesson, PJ
Citation: Fo. Marra et al., Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: A Canadian hospital perspective, ANN PHARMAC, 33(2), 1999, pp. 156-162
Authors:
Frighetto, L
Loewen, PS
Dolman, J
Marra, CA
Citation: L. Frighetto et al., Cost-effectiveness of prophylactic dolasetron or droperidol vs rescue therapy in the prevention of PONV in ambulatory gynecologic surgery, CAN J ANAES, 46(6), 1999, pp. 536-543
Authors:
Marra, CA
de Alaniz, MJT
Citation: Ca. Marra et Mjt. De Alaniz, Acyl-CoA synthetase activity in liver microsomes from calcium-deficient rats, LIPIDS, 34(4), 1999, pp. 343-354
Authors:
Loewen, PS
Marra, CA
Marra, F
Citation: Ps. Loewen et al., Systematic review of the treatment of early lyme disease, DRUGS, 57(2), 1999, pp. 157-173
Risultati:
1-15
|